Simultaneous determination of albendazole and praziquantel in rat plasma by HPLC-UV

A simple, sensitive and easy high-performance liquid chromatographic [HPLC] method has been developed and validated for the simultaneous estimation of albendazole [ABZ] and praziquantel [PRQ] using diazepam as an internal standard in rat plasma. Extraction of ABZ, PRQ and Diazepam in rat plasma was carried out by a process which involves precipitation of proteins called protein precipitation. Protein precipitation method was done by using 8.25% v/v perchloric acid. Chromatographic separations were performed using an Enable C18 column [250 mm × 4.6 mm, 5 μm: Spinco Biotech Pvt. Ltd]. The mobile phase consisted of acetonitrile: water [60:40, v/v] at a flow rate of 1.0 mL min-1 at an ambient temperature for plasma samples. The above method was developed and validated over the range from 50-8000 ng mL-1 for both ABZ and PRQ in the rat plasma. The recovery of ABZ was found to be 97.81 to 105.28%, whereas PRQ recoveries ranged from 96.80 to 102.63% in the rat plasma. Acceptable Intra-day and inter-day assay precision [<15% R.S.D.] and accuracy [<15% R.S.D.] were observed over 50–8000 ng mL-1 for ABZ and PRQ in rat plasma. This method can be effectively applied to the pharmacokinetic study of albendazole and praziquantel in rat plasma to determine all the pharmacokinetic parameters.

[1]  H. Jung-Cook,et al.  Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies. , 2006, Journal of Antimicrobial Chemotherapy.

[2]  N. Medlicott,et al.  Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma. , 2005, Journal of pharmaceutical and biomedical analysis.

[3]  N. Lopes,et al.  Biomimetic oxidation of praziquantel catalysed by metalloporphyrins , 2005 .

[4]  K. Kieć‐Kononowicz,et al.  The research on biotransformation of praziquantel. , 2004, Acta Poloniae Pharmaceutica - Drug Research.

[5]  Xiaoyan Chen,et al.  Simultaneous determination of albendazole and its major active metabolite in human plasma using a sensitive and specific liquid chromatographic-tandem mass spectrometric method. , 2004, Journal of pharmaceutical and biomedical analysis.

[6]  K. Pengsaa,et al.  Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis , 2004, Annals of tropical medicine and parasitology.

[7]  A. Dash,et al.  Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  O. Takayanagui Therapy for neurocysticercosis , 2004, Expert review of neurotherapeutics.

[9]  A. Goudah Aspects of the Pharmacokinetics of Albendazole Sulphoxide in Sheep , 2003, Veterinary Research Communications.

[10]  A. Flisser,et al.  Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. , 2003, Acta tropica.

[11]  P. S. Bonato,et al.  Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  M. Rouini,et al.  A high performance liquid chromatography method for simultaneous determination of albendazole metabolites in human serum. , 2002, Journal of pharmaceutical and biomedical analysis.

[13]  L. Fleckenstein,et al.  HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. , 2002, Journal of pharmaceutical and biomedical analysis.

[14]  P. S. Bonato,et al.  Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis. , 2002, British journal of clinical pharmacology.

[15]  M. Wongnawa,et al.  LC determination of praziquantel in human plasma. , 2002, Journal of pharmaceutical and biomedical analysis.

[16]  J. Bligh,et al.  A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London. , 2002, Annals of the Royal College of Surgeons of England.

[17]  G. Blaschke,et al.  Investigation of praziquantel metabolism in isolated rat hepatocytes. , 2001, Journal of pharmaceutical and biomedical analysis.

[18]  E. Formentini,et al.  Pharmacokinetics of ricobendazole in calves. , 2001, Journal of veterinary pharmacology and therapeutics.

[19]  G. Blaschke,et al.  Capillary electrophoresis-mass spectrometry, liquid chromatography-mass spectrometry and nanoelectrospray-mass spectrometry of praziquantel metabolites. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[20]  W. Thormann,et al.  Therapeutic drug monitoring of albendazole: Determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresis , 2000, Electrophoresis.

[21]  F. Bolás-Fernández,et al.  Quantitative determination of albendazole and its main metabolites in plasma. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[22]  J. Torrado,et al.  A Selective and Simple RP-HPLC Assay To Quantify Albendazole Metabolites in Plasma , 1998 .

[23]  M. A. al Karawi,et al.  Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. , 1998, Hepato-gastroenterology.

[24]  Cobo,et al.  Albendazole plus praziquantel versus albendazole alone as a pre‐operative treatment in intra‐abdominal hydatidosis caused by Echinococcus granulosus , 1998, Tropical medicine & international health : TM & IH.

[25]  G. Blaschke,et al.  Investigation of the stereoselective metabolism of praziquantel after incubation with rat liver microsomes by capillary electrophoresis and liquid chromatography-mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[26]  P. S. Bonato,et al.  Determination of albendazole metabolites in plasma by HPLC. , 1994, Journal of analytical toxicology.

[27]  M. A. al Karawi,et al.  Combination of praziquantel and albendazole in the treatment of hydatid disease. , 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[28]  F. Westhoff,et al.  High-performance liquid chromatographic determination of the stereoselective biotransformation of the chiral drug praziquantel. , 1992, Journal of chromatography.

[29]  V. Lanchote,et al.  Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis. , 2004, Chirality.

[30]  G. Schmahl,et al.  Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite onSchistosoma mansoni in vitro , 2004, Parasitology Research.

[31]  D. Guo,et al.  [Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis]. , 2003, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.